Skip to content

Effect of hyperinflation with manual resuscitator on postoperative pulmonary complications in patients on intraoperative high inspired oxygen fraction

Effect of hyperinflation with manual resuscitator on postoperative pulmonary complications in patients on intraoperative high inspired oxygen fraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098047
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-03-03
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pulmonary complications

Interventions

control group:Before removing the endotracheal tube, the lung hyperinflation are preformed 8 to 10 times with pure oxygen (FiO2 100%) through an anesthesia machine
exprimental group:Before removing the endotracheal tube, the lung hyperinflation are preformed 8 to 10 times with air (FiO2 21%) through a manual resuscitator

Sponsors

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients >= 18 years of age, ASA classification I - III, elective abdominal surgery, expected operative time > 2 hours, planned extubation in the operating room.

Exclusion criteria

Exclusion criteria: age 30 kg/m^2 pregnant or breastfeeding; diagnosis or suspicion of intracranial hypertension, psychiatric disorders, cognitive dysfunction; patients with apnea syndrome and suspected difficult airway; mechanical ventilation (including CPAP) within the last 15 days, pneumothorax or large buboes, COPD requiring oxygen or CPAP, history of acute lung injury or acute respiratory distress syndrome within the last 3 months; severe coronary artery disease, NYHA cardiac function class III - IV, right heart failure; severe liver disease (e.g., liver failure); chronic liver disease (e.g., hepatic failure) history of acute lung injury or acute respiratory distress syndrome within the last 3 months; severe coronary artery disease, NYHA cardiac function class III - IV, right heart failure; severe liver disease (e.g., hepatic failure); chronic renal failure (glomerular filtration rate < 30 ml/min /1.73 m^2); and patients consenting to other interventional trials.

Design outcomes

Primary

MeasureTime frame
Postoperative atelectasis;

Secondary

MeasureTime frame
Oxygenation index;Hypoxemia associated with hyperinflation ;Bradycardia associated with hyperinflation ;hypotension associated with hyperinflation ;use of Vasoactive drug;Postoperative respiratory tract infection;Postoperative respiratory failure;Postoperative pleural effusion;Postoperative nausea and vomiting;Postoperative pain;Postoperative non-planed transferred to ICU;Length of Hospital Stay;Postoperative mortality;

Countries

China

Contacts

Public ContactQiang Lyu

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

qingmu119120@163.com+86 177 0813 0229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026